Formiga Francesc, Reñe Ramón, Pérez-Maraver Manuel
Programa de Geriatría, Servicio de Medicina Interna, Hospital Universitari de Bellvitge, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, España.
Servicio de Neurología, Hospital Universitari de Bellvitge, Instituto de Investigación Biomédica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, España.
Med Clin (Barc). 2015 Feb 20;144(4):176-80. doi: 10.1016/j.medcli.2014.01.026. Epub 2014 Mar 13.
Several studies have reported the existence of an epidemiological association between diabetes mellitus (DM) and dementia. Although this association is more evident for vascular dementia, it is also described in Alzheimer's disease (AD). In this review we evaluate the different hypotheses that may explain the association between DM and dementia. We can consider the existence of a diabetes type 3 as the situation that occurs when hyperinsulinemia in response to insulin resistance leads to a decrease of the brain insulin and a poor regulation of insulin-degrading enzyme; thus, beta-amyloid accumulates, among other mechanisms, by the decline of its degradation by insulin-degrading enzyme. Consequently, AD may be related, at least in part, to a brain insulin resistance. There are several studies that prove the concept that a better metabolic control, especially in not very old people, is associated with an increased cognitive performance. It is not known whether the use of any specific drug for the treatment of DM is better than any other. It is important for physicians responsible for the metabolic control of diabetic patients to know this possible association, and to explore cognition in the control visits of patients with DM.
多项研究报告了糖尿病(DM)与痴呆症之间存在流行病学关联。尽管这种关联在血管性痴呆中更为明显,但在阿尔茨海默病(AD)中也有描述。在本综述中,我们评估了可能解释DM与痴呆症之间关联的不同假说。我们可以认为,当胰岛素抵抗导致的高胰岛素血症引起脑胰岛素减少以及胰岛素降解酶调节不良时,就会出现3型糖尿病的情况;因此,β-淀粉样蛋白会因胰岛素降解酶对其降解作用的下降等机制而积累。因此,AD可能至少部分与脑胰岛素抵抗有关。有多项研究证实了这样一个概念,即更好的代谢控制,尤其是在不太年老的人群中,与认知能力的提高有关。目前尚不清楚使用任何一种治疗DM的特定药物是否比其他药物更好。负责糖尿病患者代谢控制的医生了解这种可能的关联,并在糖尿病患者的控制访视中探索认知情况非常重要。